BRIEF published on 09/27/2024 at 08:05, 1 month 24 days ago Thalassa Holdings Ltd: 2024 Interim Financial Results Financial Performance Market Conditions Investment Holdings Interim Results Thalassa Holdings
PRESS RELEASE published on 09/27/2024 at 08:00, 1 month 24 days ago Thalassa Holdings Ltd: 2024 Interim Results Thalassa Holdings Ltd announces unaudited 2024 Interim Results showing improved financial performance and strategic investments. Chairman's statement reflects market observations and future expectations Financial Performance Strategic Investments Thalassa Holdings Ltd 2024 Interim Results Market Observations
BRIEF published on 08/14/2024 at 15:56, 3 months 6 days ago Thalassa Holdings Ltd Increases Stake in Surgical Innovations Group plc Acquisition London Stock Exchange Minimally Invasive Surgery Thalassa Holdings Surgical Innovations
PRESS RELEASE published on 08/14/2024 at 15:51, 3 months 6 days ago Thalassa Holdings Ltd: Trading Update Thalassa Holdings Ltd announces acquisition of 8,000,000 shares in Surgical Innovations Group plc, increasing stake to 10.80%. Visit https://www.sigroupplc.com/ for more info Acquisition Investment Stake Increase Thalassa Holdings Ltd Surgical Innovations Group Plc
BRIEF published on 07/29/2024 at 13:08, 3 months 23 days ago Thalassa Holdings Ltd: Trading Update Acquisition Healthcare Thalassa Holdings SAFE SAS Surgical Innovation
PRESS RELEASE published on 07/29/2024 at 13:03, 3 months 23 days ago Thalassa Holdings Ltd: Trading Update Thalassa Holdings Ltd announces acquisition of 10.09% stake in Safe Group, a French company revolutionizing services for back pain treatment. Investor inquiries: enquiries@thalassaholdingsltd.com Acquisition Investment Trading Update Thalassa Holdings Ltd Safe Group
BRIEF published on 06/28/2024 at 08:35, 4 months 23 days ago Thalassa Holdings Ltd: Trading Update Investment Losses Trading Update Thalassa Holdings Restitution Payments Mr Soukup
PRESS RELEASE published on 06/28/2024 at 08:30, 4 months 23 days ago Thalassa Holdings Ltd: Trading Update Thalassa Holdings Ltd provides a trading update following a voluntary contribution by the Chairman, with initial restitution payments made and a commitment for future contributions Investment Chairman Trading Update Thalassa Holdings Ltd Voluntary Contribution
BRIEF published on 06/13/2024 at 11:59, 5 months 8 days ago Thalassa Holdings Ltd: Results of AGM Transparency AGM Results Shareholder Support Resolutions Passed Thalassa Holdings
PRESS RELEASE published on 06/13/2024 at 11:54, 5 months 8 days ago Thalassa Holdings Ltd: Results of AGM Thalassa Holdings Ltd successfully passes all resolutions at the Annual General Meeting held on 12 June 2024 Annual General Meeting Voting Results AGM Resolutions Thalassa Holdings Ltd
Published on 11/21/2024 at 14:00, 14 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 14 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 14 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 44 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 39 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 59 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 16 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 54 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 29 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
